Simon Birk Kjaer Jensen (Simon Birk Kjær Jensen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Systematic Review

Cardiovascular Risk Factors

Top Venues

Obesity reviews : an official journal of the International Association for the Study of Obesity

This page only lists publications with an associated author ORCID identifier.

Publications

Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjaer Jensen, Signe Sørensen Torekov
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obesity reviews : an official journal of the International Association for the Study of Obesity 25 (5) (2024)
Simon Birk Kjaer Jensen, Julie Rehné Lundgren, Charlotte Janus, Christian Rimer Juhl, Lisa Møller Olsen, Mads Rosenkilde, Jens Juul Holst, Bente Merete Stallknecht, Sten Madsbad, Signe Sørensen Torekov
Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet. BMJ open 9 (11) (2019)